beta
Trial Radar AI
One study matched filter criteria
Card View
Back to Search

Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes (SELECT HCL) 100 Hybrid Study

Recruiting
Clinical Trial NCT07177404 (SELECT HCL) is an observational study for Diabete Mellitus, Type 1 Diabetes Mellitus that is recruiting. It started on September 1, 2025 with plans to enroll 100 participants. Led by University of Nottingham, it is expected to complete by February 1, 2026. The latest data from ClinicalTrials.gov was last updated on September 24, 2025.
Brief Summary
Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper unde...Show More
Detailed Description

This is a cross-sectional online survey study, which involves people with type 1 diabetes who use closed-loop, wait to start closed-loop or considering closed-loop.

The primary objective of the study is to explore the factors driving the choices of people living with type 1 diabetes regarding closed-loop therapy.

The secondary objectives of the study are:

  • To understand what treatment satisfaction with closed-loo...
Show More
Official Title

Surveying Experiences and Lifestyle Effects in Choosing Technology and Hybrid Closed Loop in Type 1 Diabetes

Conditions
Diabete MellitusType 1 Diabetes Mellitus
Other Study IDs
  • SELECT HCL
  • 25026
NCT ID Number
NCT07177404
Start Date (Actual)
2025-09
Last Update Posted
2025-09-24
Completion Date (Estimated)
2026-02
Enrollment (Estimated)
100
Study Type
Observational
Status
Recruiting
Keywords
Diabetes mellitus
Type 1 Diabetes Mellitus
Hybrid Closed Loop
Automated Insulin Delivery
Patient survey
Survey
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Ranking of factors influencing the choice of closed-loop therapy among people with type 1 diabetes
Day 1
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Ranking of factors contributing to treatment satisfaction with closed-loop therapy
Day 1
Distribution of responses to 5-point Likert scale questions assessing factors contributing to treatment satisfaction with closed-loop therapy
Day 1
Distribution of responses to 5-point Likert scale questions assessing the support needs of people using closed-loop therapy
Day 1
Associations of demographics and reported glucose levels with factors influencing the choice of closed-loop therapy
Day 1
Associations of demographics and reported glucose levels with factors contributing to treatment satisfaction with closed-loop therapy
Day 1
Associations of demographics and reported glucose levels with support needs related to closed-loop therapy
Day 1
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Age: ≥18 years (no upper age limit)
  • Type 1 diabetes (any duration)
  • People who use closed-loop therapy or wait to start closed-loop therapy or considering closed-loop therapy in the future
  • Ability to give informed consent

  • Any other type of diabetes apart from type 1 diabetes
University of Nottingham logoUniversity of Nottingham
Study Central Contact
Contact: Emma Wilmot, 0044 1332 258268, [email protected]
Contact: Alexandros Liarakos, [email protected]
1 Study Locations in 1 Countries
University Hospitals of Derby and Burton, Derby, United Kingdom
Alexandros Liarakos, Contact, 0044 1332 258268, [email protected]
Recruiting